Abstract
Experimental chemotherapy with 5‐fluorouracil (5‐FU; 60 mg/kg), l‐hexylcarbamoyl‐5‐fluorouracil (HCFU; 70 mg/kg), 3‐(3‐(6‐benzoyloxy‐3‐cyano‐2‐pyridyloxycarbonyI)benzoyl)‐l‐ethoxymethyl‐5‐fluorouracil (BOF‐A2; 30 mg/kg) and UFT (20 mg/kg as tegafur with uracil at a molar ratio of 1:4) was performed using human gastric (H‐111) and colon (Co‐4) carcinoma strains in nude mice. 5‐FU was administered ip with a q4d × 3 schedule and the other agents were given po daily for three weeks. Concentrations of 5‐FU in the serum and the tumor were assessed by gas chromatography‐ntass fragmentography, two hours or 12 days (5‐FU) after the last treatment, and thymidy late synthetase (TS) was assayed according to the method of Spears et al. using the same schedule. The antitumor activity of the agents was assessed in terms of the actual tumor weight at the end of the experiment. HCFU was effective against both strains and 5‐FU was effective against Co‐4, although the other agents were ineffective against either strain. Statistically significant correlations were found between the serum and tumor concentrations of 5‐FU and antitumor activity. Statistically significant correlations were also observed between the antitumor activity and TS inhibition rate (TSIR) and the activity of free thymidylate synthetase (TSfree), with higher TSIR and lower TSfree resulting in higher antitumor activity. Therefore, TSIR and TSfree were thought to be promising indicators for predicting the antitumor activity of fluoropyrimidines.
Keywords: Fluoropyrimidine, Human tumor xenograft Nude mouse, Thymidylate synthetase, Drug concentration
Full Text
The Full Text of this article is available as a PDF (414.4 KB).
REFERENCES
- 1. ) Spears , C. P. , Shahinian , A. M. , Moran , R. G. , Heidelberger , C. and Corbett , T. H.In vivo kinetics of thymidylate synthetase inhibition on 5 ‐fluorouracil‐sensitive and ‐resistant murine colon adenocarcinomas . Cancer Res. , 42 , 450 – 456 ( 1982. ). [PubMed] [Google Scholar]
- 2. ) Spears , C. P. , Gustavsson , B. G. , Mitchell , M. S. , Spicer , D. , Berne , M. , Bernstein , L. and Danenberg , P. V.Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5 ‐fluorouracil . Cancer Res. , 44 , 4144 – 4180 ( 1984. . [PubMed] [Google Scholar]
- 3. ) Nakamura , H. , Wang , Y. , Miyauchi , S. , Nishioka , N. , Tanaka , H. , Harada , N. , Shirasaka , T. and Fujii , S.Studies on the mechanism of antitumor activity of 5‐FU and its derivatives–relationship between the inhibition of tumor growth and the inhibition of thymidylate synthase in vivo . Jpn. J. Cancer Chemother. , 11 , 1049 – 1055 ( 1984. ) ( in Japanese ). [PubMed] [Google Scholar]
- 4. ) Mabuchi , K. , Kaneko , H. and Kobari , T.Inhibition rate of thymidylate synthetase and concentration of FdUMP and dUMP in mouse tumor after administration of 5‐fluorouracil . Jpn. Pharmacol. Ther. , 14 , 5683 – 5690 ( 1986. ) ( in Japanese ). [Google Scholar]
- 5. ) Nishiyama , M. , Takagami , S. , Kim , R. , Kirihara , Y. , Saeki , T. , Jinushi , K. , Niimoto , M. and Hattori , T.Inhibition of thymidylate synthetase and antiproliferative effect by l‐hexylcarbamoyl‐5‐fluorouracil . Jpn. J. Cancer Chemother. , 15 , 3109 – 3113 ( 1988. ) ( in Japanese ). [PubMed] [Google Scholar]
- 6. ) Kubota , T. , Nakada , M. , Tsuyuki , K. , Inada , T. , Asanuma , F. , Ishibiki , K. and Abe , O.Cell kinetics and chemosensitivity of human carcinomas serially transplanted into nude mice . Jpn. J. Cancer Res. , 77 , 502 – 507 ( 1986. ). [PubMed] [Google Scholar]
- 7. ) Shimosato , Y. , Kameya , T. , Nagai , K. , Hirohashi , S. , Koide , T. , Hayashi , H. and Nomura , T.Transplantation of human tumors in nude mice . J. Natl. Cancer Inst. , 56 , 1251 – 1260 ( 1976. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Fujii , S. , Fukusima , M. , Shimamoto , Y. , Ohshimo , H. , Imaoka , T. and Shirasaka , T.Antitumor activity of BOF‐A2, a new 5‐fluorouracil derivative . Jpn. J. Cancer Res. , 80 , 173 – 181 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. ) Isobe , Y. , Kubota , T. , Asanuma , F. , Kurihara , H. , Inada , T. , Fukutomi , T. , Ishibiki , K. and Abe , O.Pharmaco‐dynamic aspects of in vitro and in vivo chemosensitivity tests . Jpn. J. Cancer Res. , 78 , 983 – 990 ( 1987. ). [PubMed] [Google Scholar]
- 10. ) Geran , R. I. , Greenberg , N. H. , Schumacher , A. M. and Abott , B. J.Protocols for screening chemical agents and natural products against animal tumors and other biological systems (third edition) . Cancer Chemother. Rep. , 3 , 51 – 61 ( 1972. ). [Google Scholar]
- 11. ) Marunaka , T. , Umeno , Y. , Nagamachi , M. , Yoshida , K. and Yoshida , M.Determination of l‐(tetrahydro‐2‐furanyl)‐5‐fluorouracil (FT‐207) and 5‐fluorouracil (5‐FU) in biological materials . lyaku Kenkyu , 11 , 307 – 313 ( 1980. ) ( in Japanese ). [Google Scholar]
- 12. ) Evans , R. M. , Laskin , J. D. and Hakala , M.Assessment of growth‐limiting events caused by 5‐fluorouracil in mouse cells and human cells , Cancer Res. , 40 , 4113 – 4122 ( 1980. ). [PubMed] [Google Scholar]
- 13. ) Bleyer , W. A.New vistas for leucovorin in cancer chemotherapy . Cancer , 63 , 995 – 1007 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Rustum , Y. M.Toxicity and antitumor activity of 5‐fluorouracil in combination with leucovorin . Cancer , 63 , 1013 – 1017 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Kubota , T. , Ishibiki , K. and Abe , O.The clinical usefulness of human xenografts . In “ Prediction of Response to Cancer Therapy ”, ed. Hall T. C. , pp. 213 – 225 ( 1988. ). Alan R. Liss Inc. , New York . [PubMed] [Google Scholar]
- 16. ) Mori , K. , Misono , H. , Kobayashi , A. , Kobari , T. and Yokoyama , M.Tissue level of l‐hexylcarbamoyl‐5‐fluo‐rouracil (Carmofur) on an ascites hepatoma bearing rat . Jpn. Pharmacol. Ther. , 11 , 1835 – 1842 ( 1983. ) ( in Japanese ). [Google Scholar]